Attend the virtual conference from your home, office or anywhere. You will be able to access all the presentations live from your preferred device and also contribute to the virtual Q&A and chat functions.
ADATS was launched for healthcare professionals in Australia in 2017, to provide an access to the latest information on diabetes advancements and technologies.
The event is the result of the commitment by the NADC to improve the knowledge and skills of healthcare professionals in Australia. ADATS brings together world-leading experts, academics and clinicians with a shared focus and passion in advanced technologies and therapeutics in diabetes.
The 5th ADATS meeting will be a full-day virtual conference open to health care professionals both nationally and internationally and will be relevant to those that work within General Practice, Primary Care, Community Health, and Tertiary Care Centres.
The main topics that are discussed at ADATS include:
We also will have presentations on Artificial Intelligence in healthcare and how online data collection, monitoring systems, education platforms and other innovative approaches will shape the future of diabetes management
REGISTER FOR ADATS TO GET A COMPLIMENTARY BEST PRACTICE IN DIABETES CENTRES (BPDC) SYPOSIUM REGISTRATION!
ADATS registrants will be provided with a detailed certificate of attendance that can be used as evidence of continuing professional development.
Topic: Living with diabetes during COVID
DR KOREY HOOD
Topic: Leveraging telehealth and digital tools to optimize use of diabetes devices
A/PROF ANTHONY RUSSELL
Topic: Using technology to improve the level of care for people with diabetes in rural areas
A/PROF GLYNIS ROSS
Topic: What do we need to develop/improve with the technology that we are using today
DR ELAINE PRETORIUS
Topic: Diabetes Technology Standards & Accreditation
DR WILLIAM POLONSKY
Topic: Impact of PROs (Patient Reported Outcomes) on adult clinical care: why, when and how?
Topic: Automated Insulin Delivery—Best practices for onboarding and follow-up
A/PROF JANE HOLMES-WALKER
Topic: Real world data vs reality: Strategies for improvement of metabolic control in adults with T1D
DR RAHUL BARMANRAY
Topic: In-hospital Glucose Emergencies in a Digital World
Topic: Mental health care remotely/telehealth including online support/tools incl health professional
Topic: How Adults with Type 1 Diabetes Are Navigating the Challenges of Open-Source Artificial Pancreas Systems
PROF JONATHAN GOLLEDGE
Topic: Technologies to enhance accuracy of at risk foot assessment
ADATS was launched for healthcare professionals in Australia in 2017, to provide an access to the latest information on diabetes advancements and technologies. The event is the result of the commitment by the NADC to improve the knowledge and skills of healthcare professionals in Australia. ADATS brings together world-leading experts, academics and clinicians with a shared focus and passion in advanced technologies and therapeutics in diabetes.
The event is the result of the commitment of the NADC to improve the knowledge and skills of healthcare professionals in Australia in the area of diabetes and technology.
David has lived with T1 diabetes since 1982. His career has spanned IT development and systems management, professional nature/wildlife photographer, educator, and he currently works for Baker Heart and Diabetes Institute on closed-loop clinical trials. His volunteer work has covered many diabetes areas, including the ADEA program organising committee for recent ADCs, and in a working group developing the NHMRC-approved Living Evidence for Diabetes Guidelines. Through the #dedoc˚ Voices program he has been able to participate in several international diabetes conferences during COVID.
His Bionic Wookiee blog has become a reference point for much of the Australian community on issues to do with diabetes technology. Long active in the “looping” community, David has presented on that topic at previous ADAT Summits
The last two years have given us many new challenges. Both through spending a lot of time locked-down, but also at other stages through new barriers to spending time with our HCPs.
The digital tools we use today to help track and manage our conditions have certainly been a great help, although getting everyone to engage with them is still an issue. Both for existing PWDs and for people with new diagnoses.
David will outline some of the highs and lows of the last two years from a patient perspective.
Korey Hood, PhD is a Professor and Staff Psychologist at Stanford University School of Medicine. Dr. Hood directs clinical research aimed at promoting health and quality of life outcomes for people with type 1 diabetes. Dr. Hood and his research team have published over 165 scientific articles on these topics and are active presenters at diabetes, behavioral medicine, and advocacy conferences.
Dr. Hood also works in clinical and service settings. He is a licensed clinical psychologist and is part of the diabetes care team at Stanford. He is the past chair of the American Diabetes Association’s Behavioral Medicine and Psychology Interest Group and is currently a member of the Research Policy Committee. He was also a member of the ADA’s Call to Congress in March 2017.
Dr. Hood is a recent Associate Editor for both Diabetes Care and Pediatric Diabetes, and through funding from the Helmsley Charitable Trust he led the creation of DiabetesWise.org which offers free and unbranded access to available diabetes devices.
Starting diabetes devices can be both exciting and stressful. It is even trickier when more and more of diabetes care is done remotely via telehealth. This presentation will focus on ways to maximize the experience for the person with diabetes starting on diabetes devices and how to effectively use telehealth.
Tony is Director of the Department of Diabetes and Endocrinology at the Princess Alexandra Hospital, a pre-Eminent staff specialist for Queensland Health and an Adjunct Associate Professor with the Centres for Health Services Research at The University of Queensland.
Tony’s research interests are around models of care for management of diabetes. He has established an integrated model of care for the management of complex Type 2 diabetes, established a telehealth service delivering Endocrine services to a number of centres in rural and remote Queensland and tested the use of mHealth technology in a new model of care in a tertiary diabetes service.
Associate Professor Glynis Ross is a Visiting Endocrinologist at Royal Prince Alfred Hospital, and a Senior Staff Specialist at Bankstown-Lidcombe Hospital. Glynis was on the Australian Diabetes Society (ADS) Council 2012-2020 and is currently the Immediate Past President.
Her major clinical and research interests are Diabetes in Pregnancy, Type 1 Diabetes, Insulin Pump Therapy and In-patient Diabetes Management. Dr Ross serves on State and National working parties in these areas. She has been Lead Endocrinologist of the Diabetes and Pregnancy service at RPAH for 30 years. She was on the Australasian Diabetes in Pregnancy Society (ADIPS) Council from 1991-1998 and 2002-2010 (President 2008-2010).
She is involved in the teaching programs of the ADS, Australasian Colleges of Obstetrics & Gynaecology (RANZCOG), and Physicians (RACP), and Primary Care.
Dr Pretorius is the Executive Director of Medical Services for the Limestone Coast Local Health Network, South Australia. She has been a member of the National Australian Diabetes Centres Steering Committee since inception and the Chair of the NADC Accreditation Committee. She is a member of the NADC Foot Network Executive Committee and participated in the development of national standards for accreditation of foot services.
She trained in South Africa as an Endocrinologist and General Physician and came to Australia in 2004 to join the Endocrinology team at Flinders Medical Centre. Dr Pretorius was the Head of Unit for the Diabetes and Endocrine Services and subsequently the Divisional Director for Medicine in the Northern Adelaide Local Network. She was based in NALHN from 2006-2019. She counts clinical governance, quality improvement and change management as special areas of interest.
Dr Pretorius has completed a Master’s Degree in Health Care Management and completed a Fellowship in Medical Administration in 2018.
Dr Pretorius is a passionate cat lover, politics tragic and enjoys embroidery and theatre-going in her spare time.
Dr. Polonsky is President and Co-Founder of the Behavioral Diabetes Institute, the world’s first organization wholly dedicated to studying and addressing the unmet psychological needs of people with diabetes. He is also Associate Clinical Professor in Medicine at the University of California, San Diego.
Dr. Polonsky received his PhD in clinical psychology from Yale University and has served as Senior Psychologist at the Joslin Diabetes Center in Boston, faculty member at Harvard Medical School and Chairman of the National Certification Board for Diabetes Educators.
A licensed clinical psychologist, certified diabetes care and educational specialist, and highly-cited research scientist (with more than 100 peer-reviewed publications in the field of behavioral diabetes), he received the American Diabetes Association’s 2020 Outstanding Educator in Diabetes Award and the American Diabetes Association’s 2014 Richard R. Rubin Award for distinguished contributions to behavioral medicine and psychology.
In the mix of diabetes technology and clinical care, there may be significant benefit to assessing and addressing patient-reported outcomes (PROs), such as depression, diabetes distress, hypoglycemic fear and attitudes toward diabetes technology. When used appropriately, PRO data can serve to guide and inform key aspects of clinical care. These data, for example, can help to determine whether or not the patient will be open to diabetes technology solutions, likely to benefit from them, and likely to stay with them over the long-term.
More broadly, information from PROs can contribute to more meaningful conversations between clinicians and patients, help to identify and address obstacles to self-management (including problematic use of diabetes technology) as they arise, and serve to promote patients’ engagement in their own care.
In this brief presentation, we will consider how PROs are used and misused in clinical practice, and will provide practical tips for how they may be used most effectively.
Margaret Loh is a Registered Nurse with post graduate qualifications in Critical Care, Diabetes Education and Master of Nursing Practice. She has been specializing in Diabetes Education at St Vincent’s Hospital Melbourne since 2008.
After receiving AHPRA endorsement in 2018, her position of Credentialed Diabetes Educator was expanded to Diabetes Nurse Practitioner. Margaret has a special interest in diabetes technologies including insulin pump therapy, continuous glucose monitoring and advanced blood glucose meters. She also provides a nurse-led diabetes service to the Cardiothoracic, Day Oncology and Renal Units. Margaret is regularly involved in Healthcare Professional education for nurses, allied health and students.
She has been invited to participate in several local research projects which aim to improve outcomes of people with diabetes.
As diabetes technologies rapidly evolve and the choice of options expand, people with diabetes look to healthcare professionals as a trusted source to assist them in their decision-making.
Advice and training in preparation for transition to insulin pump therapy (including automation if selected) is not standardized, not consistent and may not always be sufficient to achieve the desired outcomes of both the person with diabetes and the healthcare professional.
This presentation aims to describe the current landscape in a tertiary hospital with clinical and research interests in diabetes technology – How we are going, where the gaps are and what changes are required.
A/Prof Jane Holmes-Walker is a Staff Specialist in the Dept of Diabetes and Endocrinology of Westmead Hospital.
She graduated from the University of Sydney with Honours in 1988. Her Endocrinology training was conducted at Westmead Hospital and The Middlesex Hospital in London. She then returned to Westmead Hospital to undertake a PhD in genetic causes of diabetes giving her insight into the complex factors contributing to insulin resistance syndromes and insulin deficiency.
Her ongoing research interests stem from her clinical involvement with the Islet cell transplant program at Westmead Hospital and in improving health service delivery for young adults with chronic disease particularly young people with Type I diabetes. She has published widely in both national and international literature particularly in the areas of diabetes and osteoporosis.
A/Prof Holmes-Walker has public clinics at Westmead Hospital and consults privately in rooms at Norwest Private Hospital and Westmead Private Hospital.
Real world registry data has shown us differences in outcomes depending on use of MDI vs insulin pump and the benefits of addition of CGM, but also revealed differences between continents in diabetes care outcomes. Learnings from Australian ADDN data are presented including the benefit of subsidised CGM for the paediatric population. However there is information about care we cannot determine from registries and in the end diabetes care is about teams, models of care and tailoring treatment to the individual. Key points from the recently published ADA/EASD Consensus on management of Type I diabetes in adults is presented.
Dr Rahul D Barmanray is an endocrinologist and general physician at The Royal Melbourne Hospital. He is currently completing his PhD in the field of inpatient diabetes with his early PhD work awarded the President’s Young Investigator’s Award at the 2020 Australasian Diabetes Congress. He is particularly interested in the ability of technology to improve patient care, healthcare outcomes, and the patient experience.
Rahul is also a committed educator and develops and delivers education to endocrinology advanced trainees through the Australian Diabetes Society, to medical students of the University of Melbourne, and to Cub Scouts at 6th Melbourne Scout Group.
Following his PhD work he plans to pursue his passions for diabetes, education, and technology as a clinician-researcher in these fields.
With up to a third of hospital inpatients having diabetes at any one time, glucose emergencies during an inpatient stay are common, contributing to significant morbidity and mortality. As common as diabetes is, however, in Australian hospitals the care of diabetes in inpatients is usually the responsibility of the admitting team.
This puts a layer between the person with diabetes and the doctors with specialist expertise in diabetes, which can delay the recognition and management of glucose emergencies. In 2019 The Royal Melbourne Hospital was the first hospital in Australia to institute networked blood glucose monitoring technology across all inpatient wards, technology that has significantly aided the detection and subsequent management of glucose emergencies.
This presentation discusses the ways in which technology assists in-hospital glucose emergency detection and management.
Jason Trethowan commenced as Chief Executive Officer at headspace in February 2017.
Jason has spent the bulk of his career in the health sector where he has been driven by a passion to improve health services and access for Australians. Before beginning at headspace he spent 18 months as CEO of the Western Victoria Primary Health Network where he implemented a new organisational structure and led the transition of three Medicare Locals into a single PHN.
He was also CEO at Barwon Medicare Local in Geelong and CEO of the General Practitioner’s Association of Geelong. Earlier in his career Jason held managerial roles within Ballarat and Geelong Health Services.
Jason is involved in many national health system networks and is currently a company director with Barwon Health and Professionals with Alzheimer’s (PALZ).
Jason holds an MBA from Deakin University and has completed graduate degrees in Health Informatics and Health Management at Monash University and La Trobe University.
Jason lives in Geelong with his wife and three young children and is an active member of the local community.
Jasmine joined The Australian Centre for Behavioural Research in Diabetes in 2018 as a full-time Research Assistant. She has a Bachelor of Science with first class Honours in Psychology from the University of Melbourne (2016). Her honours thesis focused on the mental health, quality of life and family functioning in people with epilepsy and their caregivers.
Jasmine is enrolled in a joint PhD program between Deakin University and the University of Copenhagen. Her thesis is on people with type 1 diabetes who are using “do-it-yourself” technologies (AndroidAPS, OpenAPS and Loop) to manage their diabetes.
An emerging group of people with type 1 diabetes are building and using their own open-source artificial pancreas systems (APS) – also known as “looping” or “do-it-yourself” APS. These ‘‘user-led” systems are not yet endorsed by regulatory bodies, but provide users with benefits and some challenges.
The experiences of Australian adults with type 1 diabetes using open-source APS were collected using interviews, and will be explored in this presentation.
We will discuss several interweaving psychosocial and practical strategies that they used to navigate the challenges of open-source APS.
Professor Jonathan Golledge is Head of the Queensland Research Centre for Peripheral Vascular Disease and its pre-clinical arm The Vascular Biology Unit (VBU) at the School of Medicine and Dentistry, James Cook University. Professor Golledge joined JCU in 2002 and established the Vascular Biology Unit with the aim of carrying out research intended to be translated into improved management of aortic aneurysm and other peripheral vascular conditions.
Professor Golledge holds a conjoint position between the School of Medicine and Dentistry and Queensland Health, where he works as a vascular surgeon. In addition to providing a high quality clinical service his principal aspiration is to improve management of peripheral vascular diseases. The research impact of this is evidenced by external grant support from the NIH, NHMRC, Queensland Government, NHF and other bodies. Of note in 2010 Professor Golledge led a successful bid to establish a NHMRC funded centre of research excellence for Peripheral Vascular Disease.